A commonly prescribed anxiety medication is being pulled from circulation across the United States after regulators identified a flaw in how the drug behaves inside the body. The recall involves Xanax, known generically as alprazolam, a staple treatment for anxiety and panic disorders. The action was initiated voluntarily by pharmaceutical company Viatris after testing showed […]

The postXanax recall sparks quiet concern nationwideappeared first onRolling Out.